The major threat to animal research in medicine; Novo to hold back Wegovy doses amid booming demand

Taking stock of the drug industry, from the lab to the medicine chest

May 4, 2023 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Courtesy Tulane National Primate Research Center STAT+ | NIH systems for non-human primate research fall short, threatening biomedical research "Now is the time to strengthen the systems we need for nonhuman primate research," said Kenneth Ramos, whose NASEM committee issued the report. By Ed Silverman Amid booming demand, Novo to hold back some doses of obesity drug Wegovy for new U.S. patients The company said would temporarily limit some "starter" doses for new patients in the U.S. to ensure a supply for people already on the drug. By Andrew Joseph STAT+ | A new list ranks large pharmaceutical companies by research and development Here's a look at the annual list produced by Idea Pharma and called the Pharmaceutical Innovation and Invention Index. By Matthew Herper Sarah Gonzalez for STAT 12,000 diseases lack treatments. One doctor thinks generics could yield cures A doctor who saved his own life by turning to a generic is starting to use AI to search for other hidden cures in the pharmacopeia. By Isabella Cueto

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser